Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page
- Check6 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” was added. The displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study content with a generic error screen. This reflects an access issue rather than a content update.SummaryDifference17%

- Check41 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the prior Revision: v3.6.6. This update reflects a revision to the page's documentation/versioning, without changing any study details presented to users.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a new version of the page template or metadata. It reflects an updated version rather than a change to the study information presented.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page shows a new revision tag: v3.6.5, replacing the previous v3.6.4. This reflects a newer version of the page content published by the site and does not alter the study details displayed.SummaryDifference0.1%

Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.